Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study …
JMW Hughto, A Tapper, SS Rapisarda… - … , prevention, and policy, 2023 - Springer
Background Medications for opioid use disorder (MOUD; methadone, buprenorphine,
naltrexone) are the most effective treatments for OUD, and MOUD is protective against fatal …
naltrexone) are the most effective treatments for OUD, and MOUD is protective against fatal …
The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of …
Background: The relationship between cannabis use and the risk of returning to using
opioids non-medically during treatment for opioid use disorder (OUD) remains unclear …
opioids non-medically during treatment for opioid use disorder (OUD) remains unclear …
Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations
Background Co-use of stimulants and opioids is rapidly increasing. Randomized clinical
trials (RCTs) have established the efficacy of medications for opioid use disorder (MOUD) …
trials (RCTs) have established the efficacy of medications for opioid use disorder (MOUD) …
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances
Objective Patients in treatment with medications for opioid use disorder (MOUD) often report
use of other substances in addition to opioids. Few studies exist that examine the …
use of other substances in addition to opioids. Few studies exist that examine the …
The impact of opioid-stimulant co-use on tonic and cue-induced craving
M Hochheimer, JC Strickland, JA Rabinowitz… - Journal of Psychiatric …, 2023 - Elsevier
The twin opioid-stimulant epidemics have led to increased overdose deaths and present
unique challenges for individuals entering treatment with opioid-stimulant polysubstance …
unique challenges for individuals entering treatment with opioid-stimulant polysubstance …
[HTML][HTML] The Emergence of the Old Drug Captagon as a New Illicit Drug: A Narrative Review
J Pergolizzi Jr, JAK LeQuang, E Vortsman… - Cureus, 2024 - ncbi.nlm.nih.gov
First developed in the 1960s in Europe and approved briefly for use in the United States,
fenethylline (sold as Captagon, one of its early trade names) is now a prominent drug of …
fenethylline (sold as Captagon, one of its early trade names) is now a prominent drug of …
Prenatal substance use and mental health comorbidities predict continued use.
ES Kruger, A Rodriguez, L Leeman… - Psychology of Addictive …, 2024 - psycnet.apa.org
Objective: Prenatal substance use is common and can affect maternal and infant health. In
addition, prenatal substance use is associated with mental health comorbidities (depression …
addition, prenatal substance use is associated with mental health comorbidities (depression …
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and …
Background We use a novel, longitudinal approach to describe average time spent in opioid
use disorder (OUD) cascade of care stages for people with HIV (PWH) and with OUD …
use disorder (OUD) cascade of care stages for people with HIV (PWH) and with OUD …
Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary …
Abrégé Objectifs Les données probantes sont limitées en ce qui concerne la façon dont le
traitement agoniste opioïde (TAO) peut influencer l'utilisation de substances psychoactives …
traitement agoniste opioïde (TAO) peut influencer l'utilisation de substances psychoactives …
The Emergence of the Old Drug Captagon as a New Illicit Drug: A Narrative Review
V Eugene, P Magnusson, SN EL-Tallawy, M Wagner… - Cureus, 2024 - search.proquest.com
First developed in the 1960s in Europe and approved briefly for use in the United States,
fenethylline (sold as Captagon, one of its early trade names) is now a prominent drug of …
fenethylline (sold as Captagon, one of its early trade names) is now a prominent drug of …